AU2002316299A1 - Ppar-alpha ligands for the treatment or prevention of cachexia - Google Patents
Ppar-alpha ligands for the treatment or prevention of cachexiaInfo
- Publication number
- AU2002316299A1 AU2002316299A1 AU2002316299A AU2002316299A AU2002316299A1 AU 2002316299 A1 AU2002316299 A1 AU 2002316299A1 AU 2002316299 A AU2002316299 A AU 2002316299A AU 2002316299 A AU2002316299 A AU 2002316299A AU 2002316299 A1 AU2002316299 A1 AU 2002316299A1
- Authority
- AU
- Australia
- Prior art keywords
- ppar
- cachexia
- prevention
- treatment
- alpha ligands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30027401P | 2001-06-22 | 2001-06-22 | |
US60/300,274 | 2001-06-22 | ||
PCT/US2002/019464 WO2003000182A2 (en) | 2001-06-22 | 2002-06-19 | Ppar-alpha ligands for the treatment or prevention of cachexia |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002316299A1 true AU2002316299A1 (en) | 2003-01-08 |
Family
ID=23158415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002316299A Abandoned AU2002316299A1 (en) | 2001-06-22 | 2002-06-19 | Ppar-alpha ligands for the treatment or prevention of cachexia |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002316299A1 (en) |
WO (1) | WO2003000182A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2577601A1 (en) | 2004-08-13 | 2006-02-16 | Indivumed Gmbh | Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9606805D0 (en) * | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
US5925657A (en) * | 1997-06-18 | 1999-07-20 | The General Hospital Corporation | Use of PPARγ agonists for inhibition of inflammatory cytokine production |
-
2002
- 2002-06-19 AU AU2002316299A patent/AU2002316299A1/en not_active Abandoned
- 2002-06-19 WO PCT/US2002/019464 patent/WO2003000182A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003000182A2 (en) | 2003-01-03 |
WO2003000182A3 (en) | 2003-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
AU2935200A (en) | Compounds for the treatment of obesity | |
AU2002348135A1 (en) | Methods for the treatment of addiction | |
AU2002364300A1 (en) | Polymer derivatives for the treatment of metals | |
EP1390029A4 (en) | Phenylindoles for the treatment of hiv | |
HRP20040906B1 (en) | Bisphosphonic acid for the treatment and prevention of ostreoporosis | |
AU2002303502A1 (en) | Improved leads for the treatment of patients with chf | |
GB2418025B (en) | Device for the prevention or treatment of ulcers | |
EP1442062A4 (en) | Methods for the treatment of carcinoma | |
AU2003263760A1 (en) | Methods for the treatment or prevention of obesity | |
AU4136901A (en) | Novel methods for the treatment and prevention of dizziness and pruritus | |
PL377464A1 (en) | Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
AU5038299A (en) | Process for the biocidal treatment of surfaces | |
AU2002364171A1 (en) | Materials and methods for the treatment or prevention of obesity | |
EP1461030A4 (en) | Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma | |
AU2002249947A1 (en) | Inhibition of protein-phosphatases for the treatment of heart failure | |
AU2001285156A1 (en) | Combination therapy for the treatment of migraine | |
AU2002304883A1 (en) | Device for the treatment of tumours | |
AU2002316299A1 (en) | Ppar-alpha ligands for the treatment or prevention of cachexia | |
AU2002365621A1 (en) | Composition for treating the surface of the skin | |
AU2003268939A1 (en) | Bisphosphonates for the treatment of antheroscleorosis and devices comprising them | |
AU2002251202A1 (en) | Intimins for the prevention or treatment of infections: i | |
AU2000272704A1 (en) | Use of compounds for the treatment of obesity | |
AU1792200A (en) | Use of phanquinone for the treatment or prevention of memory impairment | |
AUPR814901A0 (en) | Water treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |